Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications

Theodora Pappa, João Anselmo, Sunnee Mamanasiri, Alexandra M. Dumitrescu, Roy E Weiss, Samuel Refetoff

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Context: Resistance to thyroid hormone-β (RTH-β) is an autosomal dominant disorder characterized by reduced sensitivity of target tissues to thyroid hormones (THs). Individuals with RTH-β have high TH levels usually due to mutations in the TH receptor-β (THRB) gene. The management of RTH-β during pregnancy is challenging, as wild-type (WT) fetuses born to RTH-β mothers have low birth weight and suppressed postnatal thyroid-stimulating hormone (TSH), due to intrauterine exposure to excess TH.

Objective: To determine birth weight and postnatal TSH of WT fetuses carried by mothers with RTH-β whose fT4 levels were maintained below 20% of the upper limit of normal (ULN).

Design: Retrospective chart review.

Setting: Academic institution in collaboration with off-site hospitals and private practices.

Patients: Thirteen women harboring THRB gene mutations were evaluated during 18 pregnancies.

Intervention: Prenatal genetic diagnosis by amniocentesis. Women carrying WT fetuses were given the option of treatment with antithyroid medication by their treating physicians with the aim to avoid serum fT4 levels above 20% of the ULN.

Results: No significant difference was found in birth weight corrected for gestational age and in serum TSH levels at birth between WT and RTH-β infants born to RTH-β mothers.

Conclusions: Prenatal diagnosis may play an important role in the management of RTH-β during pregnancy. Aiming for maternal fT4 levels not above 50% of the ULN in RTH-β mothers carrying WT fetuses seems to be a prudent approach that prevents the otherwise expected low birth weight and postnatal TSH suppression.

Original languageEnglish (US)
Pages (from-to)3775-3782
Number of pages8
JournalThe Journal of clinical endocrinology and metabolism
Volume102
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Thyroid Hormone Resistance Syndrome
Prenatal Diagnosis
Thyroid Hormones
Thyrotropin
Mothers
erbA Genes
Fetus
Low Birth Weight Infant
Birth Weight
Pregnancy
Thyroid Hormone Receptors
Mutation
Genetic Engineering
Amniocentesis
Genes
Private Practice
Serum
Gestational Age
Parturition

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications. / Pappa, Theodora; Anselmo, João; Mamanasiri, Sunnee; Dumitrescu, Alexandra M.; Weiss, Roy E; Refetoff, Samuel.

In: The Journal of clinical endocrinology and metabolism, Vol. 102, No. 10, 01.10.2017, p. 3775-3782.

Research output: Contribution to journalArticle

Pappa, Theodora ; Anselmo, João ; Mamanasiri, Sunnee ; Dumitrescu, Alexandra M. ; Weiss, Roy E ; Refetoff, Samuel. / Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications. In: The Journal of clinical endocrinology and metabolism. 2017 ; Vol. 102, No. 10. pp. 3775-3782.
@article{8f7469c222a84185b2b50ad9cdbaf6cb,
title = "Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications",
abstract = "Context: Resistance to thyroid hormone-β (RTH-β) is an autosomal dominant disorder characterized by reduced sensitivity of target tissues to thyroid hormones (THs). Individuals with RTH-β have high TH levels usually due to mutations in the TH receptor-β (THRB) gene. The management of RTH-β during pregnancy is challenging, as wild-type (WT) fetuses born to RTH-β mothers have low birth weight and suppressed postnatal thyroid-stimulating hormone (TSH), due to intrauterine exposure to excess TH.Objective: To determine birth weight and postnatal TSH of WT fetuses carried by mothers with RTH-β whose fT4 levels were maintained below 20{\%} of the upper limit of normal (ULN).Design: Retrospective chart review.Setting: Academic institution in collaboration with off-site hospitals and private practices.Patients: Thirteen women harboring THRB gene mutations were evaluated during 18 pregnancies.Intervention: Prenatal genetic diagnosis by amniocentesis. Women carrying WT fetuses were given the option of treatment with antithyroid medication by their treating physicians with the aim to avoid serum fT4 levels above 20{\%} of the ULN.Results: No significant difference was found in birth weight corrected for gestational age and in serum TSH levels at birth between WT and RTH-β infants born to RTH-β mothers.Conclusions: Prenatal diagnosis may play an important role in the management of RTH-β during pregnancy. Aiming for maternal fT4 levels not above 50{\%} of the ULN in RTH-β mothers carrying WT fetuses seems to be a prudent approach that prevents the otherwise expected low birth weight and postnatal TSH suppression.",
author = "Theodora Pappa and Jo{\~a}o Anselmo and Sunnee Mamanasiri and Dumitrescu, {Alexandra M.} and Weiss, {Roy E} and Samuel Refetoff",
year = "2017",
month = "10",
day = "1",
doi = "10.1210/jc.2017-01251",
language = "English (US)",
volume = "102",
pages = "3775--3782",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications

AU - Pappa, Theodora

AU - Anselmo, João

AU - Mamanasiri, Sunnee

AU - Dumitrescu, Alexandra M.

AU - Weiss, Roy E

AU - Refetoff, Samuel

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Context: Resistance to thyroid hormone-β (RTH-β) is an autosomal dominant disorder characterized by reduced sensitivity of target tissues to thyroid hormones (THs). Individuals with RTH-β have high TH levels usually due to mutations in the TH receptor-β (THRB) gene. The management of RTH-β during pregnancy is challenging, as wild-type (WT) fetuses born to RTH-β mothers have low birth weight and suppressed postnatal thyroid-stimulating hormone (TSH), due to intrauterine exposure to excess TH.Objective: To determine birth weight and postnatal TSH of WT fetuses carried by mothers with RTH-β whose fT4 levels were maintained below 20% of the upper limit of normal (ULN).Design: Retrospective chart review.Setting: Academic institution in collaboration with off-site hospitals and private practices.Patients: Thirteen women harboring THRB gene mutations were evaluated during 18 pregnancies.Intervention: Prenatal genetic diagnosis by amniocentesis. Women carrying WT fetuses were given the option of treatment with antithyroid medication by their treating physicians with the aim to avoid serum fT4 levels above 20% of the ULN.Results: No significant difference was found in birth weight corrected for gestational age and in serum TSH levels at birth between WT and RTH-β infants born to RTH-β mothers.Conclusions: Prenatal diagnosis may play an important role in the management of RTH-β during pregnancy. Aiming for maternal fT4 levels not above 50% of the ULN in RTH-β mothers carrying WT fetuses seems to be a prudent approach that prevents the otherwise expected low birth weight and postnatal TSH suppression.

AB - Context: Resistance to thyroid hormone-β (RTH-β) is an autosomal dominant disorder characterized by reduced sensitivity of target tissues to thyroid hormones (THs). Individuals with RTH-β have high TH levels usually due to mutations in the TH receptor-β (THRB) gene. The management of RTH-β during pregnancy is challenging, as wild-type (WT) fetuses born to RTH-β mothers have low birth weight and suppressed postnatal thyroid-stimulating hormone (TSH), due to intrauterine exposure to excess TH.Objective: To determine birth weight and postnatal TSH of WT fetuses carried by mothers with RTH-β whose fT4 levels were maintained below 20% of the upper limit of normal (ULN).Design: Retrospective chart review.Setting: Academic institution in collaboration with off-site hospitals and private practices.Patients: Thirteen women harboring THRB gene mutations were evaluated during 18 pregnancies.Intervention: Prenatal genetic diagnosis by amniocentesis. Women carrying WT fetuses were given the option of treatment with antithyroid medication by their treating physicians with the aim to avoid serum fT4 levels above 20% of the ULN.Results: No significant difference was found in birth weight corrected for gestational age and in serum TSH levels at birth between WT and RTH-β infants born to RTH-β mothers.Conclusions: Prenatal diagnosis may play an important role in the management of RTH-β during pregnancy. Aiming for maternal fT4 levels not above 50% of the ULN in RTH-β mothers carrying WT fetuses seems to be a prudent approach that prevents the otherwise expected low birth weight and postnatal TSH suppression.

UR - http://www.scopus.com/inward/record.url?scp=85032504196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032504196&partnerID=8YFLogxK

U2 - 10.1210/jc.2017-01251

DO - 10.1210/jc.2017-01251

M3 - Article

VL - 102

SP - 3775

EP - 3782

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -